Effect of Quercetin in Treatment of Periodontitis
Inflammation Gum
About this trial
This is an interventional treatment trial for Inflammation Gum focused on measuring Periodontitis, inflammation, Quarcetin, Nanoemulgel
Eligibility Criteria
Inclusion Criteria: Inclusion criteria: Patients with periodontitis stage ( Ⅰ & Ⅱ ). Stage I have CAL 1 to 2mm with no tooth loss and probing depth ≤4 mm. Stage II have CAL 3 to 4mm with no tooth loss and probing depth ≤5 mm.. Patients who have teeth with both mesial and distal neighboring teeth . Patient with more than 20 natural teeth . Patient free from any systemic disease that may effect the periodontal status according to the criteria of Cornell Medical Index and its modification. Exclusion Criteria: Long-term therapy with medications within a month prior to enrollment that could affect periodontal status or healing. Pregnant woman and lactating mothers . Patients with a history of traumatic occlusion. Teeth with both endo-perio lesion . Patients with previous periodontal treatment including scaling and root planing and periodontal surgery in the last 3 and 6 months, respectively .
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
Group(I):scaling and root planing only
Group(Ⅱ):scaling and root planing with application of quercetin nanoemulgel
10 sites will receive non-surgical periodontal therapy (scaling and root planing) .
10 sites will receive non-surgical periodontal therapy followed by the application of quercetin nanoemulgel local delivery 2 times one at the day of non-surgical periodontal therapy and after 2 weeks.